Literature DB >> 22874582

Medical management of peripheral arterial disease: bridging the "gap"?

Christopher D Owens, Michael S Conte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22874582     DOI： 10.1161/CIRCULATIONAHA.112.129692

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  Loss of interleukin-21 receptor activation in hypoxic endothelial cells impairs perfusion recovery after hindlimb ischemia.

Authors:  Tao Wang; Alexis Cunningham; Ayotunde O Dokun; Surovi Hazarika; Kevin Houston; Lingdan Chen; R John Lye; Rosanne Spolski; Warren J Leonard; Brian H Annex
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-02       Impact factor: 8.311

Review 2.  Disparities in peripheral artery disease care: A review and call for action.

Authors:  Falen Demsas; Malachi M Joiner; Kate Telma; Alyssa M Flores; Semhar Teklu; Elsie Gyang Ross
Journal:  Semin Vasc Surg       Date:  2022-05-08       Impact factor: 1.222

3.  Perioperative management with antiplatelet and statin medication is associated with reduced mortality following vascular surgery.

Authors:  Randall R De Martino; Jens Eldrup-Jorgensen; Brian W Nolan; David H Stone; Julie Adams; Daniel J Bertges; Jack L Cronenwett; Philip P Goodney
Journal:  J Vasc Surg       Date:  2014-01-16       Impact factor: 4.268

4.  Peripheral revascularization attenuates the exercise pressor reflex and increases coronary exercise hyperemia in peripheral arterial disease.

Authors:  Amanda J Miller; J Carter Luck; Danielle Jin-Kwang Kim; Urs A Leuenberger; Faisal Aziz; John F Radtka; Lawrence I Sinoway; Matthew D Muller
Journal:  J Appl Physiol (1985)       Date:  2018-04-12

5.  Prevalence, Outcome, and Management of Risk Factors in Patients With Breast Cancer With Peripheral Arterial Disease: A Tertiary Cancer Center's Experience.

Authors:  Yolanda Bryce; Richard Bourguillon; Juan Camacho Vazquez; Etay Ziv; Daehee Kim; Ernesto Santos Martin
Journal:  Clin Breast Cancer       Date:  2020-12-30       Impact factor: 3.078
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.